Figure S2. All patients (n = 414): Kaplan-Meier estimates of DFS, LRFS, and DRFS according to high (solid green lines) and low (dashed blue lines) expression of PLCγ1, PLCγ1-pY1253 and PLCγ1-pY783; Figure S3. Patients with HER2 positive breast cancer subtype (n = 27): Kaplan-Meier estimates of DFS, LRFS, and DRFS according to high (solid green lines) and low (dashed blue lines) expression of PLCγ1, PLCγ1-pY1253 and PLCγ1-pY783. Here, PLCG1 is linked to breast cancer.